Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

209 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The ageing of people living with cystic fibrosis: what to expect now?
Felipe Montiel A, Fernández AÁ, Amigo MC, Traversi L, Clofent Alarcón D, Reyes KL, Polverino E. Felipe Montiel A, et al. Among authors: amigo mc. Eur Respir Rev. 2024 Oct 30;33(174):240071. doi: 10.1183/16000617.0071-2024. Print 2024 Oct. Eur Respir Rev. 2024. PMID: 39477350 Free PMC article. Review.
Factors predictive of severe thrombocytopenia and its impact on poor outcomes in Latin American patients with systemic lupus erythematosus: Data from a multiethnic Latin American cohort.
González LA, Harvey GB, Quintana R, Pons-Estel GJ, Ugarte-Gil MF, Vásquez G, Catoggio LJ, García MA, Borba EF, Da Silva NA, Brenol JCT, Toledano MG, Massardo L, Neira O, Pascual-Ramos V, Amigo MC, Barile-Fabris LA, Torre IG, Alfaro-Lozano J, Segami MI, Chacón-Díaz R, Esteva-Spinetti MH, Iglesias-Gamarra A, Alarcón GS, Pons-Estel BA. González LA, et al. Among authors: amigo mc. Semin Arthritis Rheum. 2024 Dec;69:152568. doi: 10.1016/j.semarthrit.2024.152568. Epub 2024 Oct 11. Semin Arthritis Rheum. 2024. PMID: 39437633
Development of the 2023 ACR/EULAR Antiphospholipid Syndrome Classification Criteria, Phase III-D Report: Multicriteria Decision Analysis.
Barbhaiya M, Zuily S, Amigo MC, Andrade D, Avcin T, Bertolaccini ML, Branch DW, Costedoat-Chalumeau N, Crowther M, Ramires de Jesus G, Devreese KMJ, Frances C, Garcia D, Gómez-Puerta JA, Guillemin F, Levine SR, Levy RA, Lockshin MD, Ortel TL, Petri M, Sanna G, Sciascia S, Seshan SV, Tektonidou MG, Wahl D, Willis R, Yelnik C, Hendry A, Naden R, Costenbader K, Erkan D; ACR/EULAR APS Classification Criteria Collaborators. Barbhaiya M, et al. Among authors: amigo mc. Arthritis Care Res (Hoboken). 2024 Dec;76(12):1617-1625. doi: 10.1002/acr.25415. Epub 2024 Sep 30. Arthritis Care Res (Hoboken). 2024. PMID: 39135467
Low dose lenalidomide versus placebo in non-transfusion dependent patients with low risk, del(5q) myelodysplastic syndromes (SintraREV): a randomised, double-blind, phase 3 trial.
Díez-Campelo M, López-Cadenas F, Xicoy B, Lumbreras E, González T, Del Rey González M, Sánchez-García J, Coll Jordà R, Slama B, Hernández-Rivas JÁ, Thepot S, Bernal T, Guerci-Bresler A, Bargay J, Amigo ML, Preudhomme C, Fenwarth L, Platzbecker U, Götze KS, Arar A, Toribio S, Del Cañizo C, Hernández-Rivas JM, Fenaux P. Díez-Campelo M, et al. Among authors: amigo ml. Lancet Haematol. 2024 Sep;11(9):e659-e670. doi: 10.1016/S2352-3026(24)00142-X. Epub 2024 Jul 18. Lancet Haematol. 2024. PMID: 39033767 Clinical Trial.
Evolving patterns and clinical outcome of genetic studies performed at diagnosis in acute myeloid leukemia patients: Real life data from the PETHEMA Registry.
Labrador J, Martínez-Cuadrón D, Boluda B, Serrano J, Gil C, Pérez-Simón JA, Bernal T, Bergua JM, Martínez-López J, Rodríguez-Medina C, Vidriales MB, García-Boyero R, Algarra L, Polo M, Sayas MJ, Tormo M, Alonso-Domínguez JM, Herrera P, Lavilla E, Ramos F, Amigo ML, Vives-Polo S, Rodríguez-Macías G, Mena-Durán A, Pérez-Encinas MM, Arce-Fernández O, Cuello R, Sánchez-García J, Gómez-Casares MT, Chillón MC, Calasanz MJ, Ayala R, Rodriguez-Veiga R, Barragán E, Montesinos P; PETHEMA Group. Labrador J, et al. Among authors: amigo ml. Cancer. 2024 Oct 15;130(20):3436-3451. doi: 10.1002/cncr.35431. Epub 2024 Jun 19. Cancer. 2024. PMID: 38896056
Do NPM1 and FLT3-ITD mutations modify prognosis in patients treated with non-intensive regimens?
Suárez EU, Boluda B, Lavilla E, Tormo M, Botella C, Gil C, Vives S, Rodríguez C, Serrano J, Sayas MJ, Martínez-Sánchez P, Ramos F, Bernal T, Algarra L, Bergua-Burgues JM, Pérez-Simón JA, Herrera P, Barrios M, Noriega-Concepción V, Raposo-Puglia JA, Ayala R, Barragán E, Martínez-Cuadrón D, Amigo ML, López-Lorenzo JL, Lázaro-García A, Guimaraes JE, Colorado M, García-Boyero R, De Rueda-Ciller B, Foncillas-García M, Hong A, Labrador J, Alonso-Dominguez JM, Montesinos P; PETHEMA group. Suárez EU, et al. Among authors: amigo ml. Ann Hematol. 2024 Aug;103(8):2845-2851. doi: 10.1007/s00277-024-05840-7. Epub 2024 Jun 17. Ann Hematol. 2024. PMID: 38884787
Removing cross-cultural barriers to participation in the ISTH Congress.
Amigo MC, Mesquita Camelo R, Douketis J, Lee LH, Muia J, Nagao A, Scarlatescu E, Harper AGS. Amigo MC, et al. J Thromb Haemost. 2024 Jul;22(7):1803-1805. doi: 10.1016/j.jtha.2024.05.002. Epub 2024 May 10. J Thromb Haemost. 2024. PMID: 38849213 No abstract available.
Time to diagnosis in systemic lupus erythematosus: Associated factors and its impact on damage accrual and mortality. Data from a multi-ethnic, multinational Latin American lupus cohort.
Nieto R, Quintana R, Zavala-Flores E, Serrano R, Roberts K, Catoggio LJ, García MA, Berbotto GA, Saurit V, Bonfa E, Borba EF, Lavras Costallat LT, Da Silva NA, Sato EI, Tavares Brenol JC, Massardo L, Neira OJ, Vázquez G, Guibert Toledano M, Pascual-Ramos V, Sauza Del Pozo MJ, Barile-Fabris LA, Amigo MC, García De La Torre I, Acevedo-Vásquez EM, Segami MI, Chacón-Díaz R, Esteva-Spinetti MH, Alarcón GS, Pons-Estel BA, Pons-Estel GJ. Nieto R, et al. Among authors: amigo mc. Lupus. 2024 Apr;33(4):340-346. doi: 10.1177/09612033241232821. Epub 2024 Feb 9. Lupus. 2024. PMID: 38334100
The whole is greater than the sum of its parts: Long-read sequencing for solving clinical problems in haematology.
Bravo-Perez C, Cifuentes-Riquelme R, Padilla J, de la Morena-Barrio ME, Ortuño FJ, Garrido-Rodríguez P, Amigo ML, Heras I, Vicente V, Lozano ML, Teruel-Montoya R, de la Morena-Barrio B, Corral J. Bravo-Perez C, et al. Among authors: amigo ml. J Cell Mol Med. 2024 Feb;28(3):e17961. doi: 10.1111/jcmm.17961. Epub 2024 Jan 23. J Cell Mol Med. 2024. PMID: 38260950 Free PMC article. No abstract available.
Incidence, risk factors, and outcomes of second neoplasms in patients with acute promyelocytic leukemia: the PETHEMA-PALG experience.
Sobas M, Knopinska-Posluszny W, Piątkowska-Jakubas B, García-Álvarez F, Díez MEA, Caballero M, Martínez-Cuadrón D, Aguiar E, González-Campos J, Garrido A, Algarra L, Salamero O, de la Serna J, Sayas MJ, Perez-Encinas MM, Vives S, Vidriales B, Labrador J, Prado AI, Celebrin L, Mayer J, Brioso J, de Laiglesia A, Bergua JM, Amigo ML, Rodriguez-Medina C, Polo M, Pluta A, Cichocka E, Skarupski M, Sanz MA, Wierzbowska A, Montesinos P. Sobas M, et al. Among authors: amigo ml. Ann Hematol. 2024 Feb;103(2):451-461. doi: 10.1007/s00277-023-05582-y. Epub 2023 Dec 19. Ann Hematol. 2024. PMID: 38110588 Free PMC article.
209 results